By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Interleukin Genetics today said that it has received commitments from certain institutional investors to purchase $5.3 million of the firm's stock through a direct placement.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
The White House seeks to update how biotechnology products are regulated.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.